Project Grant R21MH136486

Award Date 9/5/24
Completion Date 7/31/26
Dollars Obligated $157K
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Irvine, CA 92697, USA
Similar Awards
The National Institute of Mental Health (NIMH) awarded a $1,401,862 Project Grant under the Mental Health Research Grants (CFDA 93.242) program to the University of California, Berkeley. The 5-year grant, which commenced on September 21, 2024, will support research to investigate the role of the orbitofrontal cortex (OFC) in inhibiting habitual responses in the striatum to enable goal-directed decision-making. The researchers will use a novel behavioral task and advanced neural recording...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $725,422 to Massachusetts Institute of Technology (MIT) to investigate the role of striatal astrocytes and the striato-nigro-striatal loop in modulating dopamine signals and behavioral state transitions. The research aims to understand how striatal astrocyte activity and dopamine signaling in the striatum are correlated with the transition of...
The National Institute of Mental Health (NIMH) awarded a $409,750 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to the University of Puerto Rico Medical Sciences Campus. This 2-year grant, effective from April 1, 2025 to March 31, 2027, will support research to characterize the role of ventral pallidal astrocytes in approach/avoidance conflict behaviors in mice. The research aims to provide insights into how astrocytes mediate approach/avoidance conflict by...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $774,632 to Northwestern University to conduct research on the neural basis of dopamine-driven deficits in cognition and perception. The project aims to use in vivo imaging to investigate how excess dopamine signaling in the dorsal striatum impacts the activity of D1 and D2 dopamine receptor-expressing spiny projection neurons, and how this...
The National Institute of Mental Health (NIMH) awarded a $422,280 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to the University of Colorado-Denver. The 2-year grant, running from April 1, 2025 to March 31, 2027, will support research to identify and interrogate novel intracellular proteins that underlie the distinct nanoscopic architecture of the synaptic adhesion molecules neurexin-1 and neurexin-3. Specifically, the research will use advanced imaging...
The National Institute of Mental Health (NIMH) awarded a $206,875 Project Grant (CFDA 93.242 - Mental Health Research Grants) to the Research Foundation For Mental Hygiene, Inc. (RFMH) to investigate the impact of GRIN2B/GLUN2B disruption on dopaminergic function and related behaviors. The project aims to use a conditional Cre/Lox strategy in mice to assess the effects of diminished GLUN2B signaling on dopaminergic neuron firing, dopamine release, and downstream behaviors such as impulsivity and...
The National Institute of Mental Health (NIMH) awarded a $431,750 Project Grant (CFDA 93.242 - Mental Health Research Grants) to the University of California, Irvine (UC Irvine) to investigate the role of the medial striatum in spatial sequence learning and its interaction with the hippocampus. The two-year study, running from September 1, 2023 to August 31, 2025, aims to evaluate how the dorsomedial striatum contributes to the disambiguation of repeated spatial traversals that occur in distinct...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants (CFDA 93.242) program, provides $1,369,101 to the University of California, Los Angeles (UCLA) to conduct research on elucidating the regulation of cell fate specification in human cortical development. The goal is to better understand the etiology of neurodevelopmental disorders. The project will evaluate the signals that drive cortical arealization and laminar...
The National Institute of Mental Health (NIMH) awarded a $1,380,070 Project Grant (CFDA 93.242 - Mental Health Research Grants) to Duke University to explore the cellular properties and circuit functional roles of human cortical interneurons. This research aims to generate a multimodal phenotypic catalog of human interneurons and characterize their functional organization in neural circuits. The project will utilize live brain specimens collected from neurosurgical procedures and a novel genetic...
The National Institute of Mental Health (NIMH) awarded a $1,453,943 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to the University of California, Los Angeles (UCLA) for the period of June 1, 2025 to May 31, 2028. The grant will fund the development of an integrated, portable sensor suite to concurrently record neural activity, physiological arousal, motor signals, and physical interactions in social environments. The project aims to track neuro-behavioral attention...

The National Institute of Mental Health (NIMH) awarded a $157,000 Project Grant (CFDA 93.242 - Mental Health Research Grants) to the University of California, Irvine. The grant supports research to determine the impact of dopamine receptor 2 (D2R) signaling in astrocytes on prefrontal cortex functions. Specifically, the project aims to use viral vectors to knockdown D2R in astrocytes of mice with normal or altered dopamine synthesis/release, in order to elucidate the role of astrocytic D2R signaling in controlling prefrontal cortex-dependent behaviors, gene expression, and metabolite production. This research is intended to provide new insights into the involvement of glial cells in neurological and psychiatric disorders. The project period runs from Sep 5, 2024 to Jul 31, 2026.

Generated 7/1/25, 4:01 AM